تعداد نشریات | 20 |
تعداد شمارهها | 1,149 |
تعداد مقالات | 10,519 |
تعداد مشاهده مقاله | 45,425,882 |
تعداد دریافت فایل اصل مقاله | 11,296,788 |
Induction of Apoptosis by a Combination of 2-Deoxyglucose and Metformin in Esophageal Squamous Cell Carcinoma by Targeting Cancer Cell Metabolism | ||
Iranian Journal of Medical Sciences | ||
مقاله 2، دوره 44، شماره 2، خرداد 2019، صفحه 99-107 اصل مقاله (849.03 K) | ||
نوع مقاله: Original Article(s) | ||
شناسه دیجیتال (DOI): 10.30476/ijms.2019.44522 | ||
نویسندگان | ||
Abbas Shafaee1؛ Jalil Pirayesh Islamian2؛ Davoud Zarei* 3؛ Mohsen Mohammadi3؛ Kazem Nejati-Koshki4؛ Alireza Farajollahi2؛ Seyed Mahmoud Reza Aghamiri5؛ Mohammad Rahmati Yamchi6؛ Behzad Baradaran7؛ Mohammad Asghari Jafarabadi8 | ||
1Department of Radiology-Faculty of Paramedicine- Tabriz University of Medical Sciences, Tabriz, Iran | ||
2Department of Medical Physics, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran | ||
3Department of Medical Radiation Science, School of Paramedicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran | ||
4Department of Medical Biotechnology, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran | ||
5Department of Radiation Medicine, Faculty of Nuclear Engineering, Shahid Beheshti University of Medical Sciences, Tehran, Iran | ||
6Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran | ||
7Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran | ||
8Department of Statistics and Epidemiology, Tabriz University of Medical Sciences, Tabriz, Iran | ||
چکیده | ||
Background: Both mitochondrial dysfunction and aerobic glycolysis are signs of growing aggressive cancer. If altered metabolism of cancer cell is intended, using the glycolysis inhibitor (2-deoxyglucose (2DG)) would be a viable therapeutic method. The AMP-activated protein kinase (AMPK), as a metabolic sensor, could be activated with metformin and it can also launch a p53-dependent metabolic checkpoint and might inhibit cancer cell growth. Methods: After treatment with 5 mM metformin and/or 500 µM 2DG, the TE1, TE8, and TE11 cellular viability and apoptosis were assessed by MTT, TUNEL, and ELISA methods. The changes in p53 and Bcl-2 genes expression levels were examined using real-time PCR method. Data were analyzed by Kruskal-Wallis test using the SPSS 17.0 software. Results: Metformin and 2DG, alone and in combination, induced apoptosis in the cell lines. Real-time PCR revealed that metformin induced apoptosis in TE8 and TE11 cells by activating p53, down-regulating Bcl-2 expression. The induced apoptosis by 2DG raised by metformin and the combination modulated the expression of Bcl-2 protein in all cell lines and it was more effective in TE11 cell line. Conclusion: Metformin induced apoptosis in ESCC by down-regulating Bcl-2 expression, and up-regulating p53 and induced apoptosis increased by 2-deoxy-d-glucose. Thus, the combination therapy is an effective therapeutic strategy for esophageal squamous cell carcinoma. | ||
کلیدواژهها | ||
2-Deoxy-D-Glucose؛ Esophageal carcinoma؛ Metformin؛ apoptosis | ||
آمار تعداد مشاهده مقاله: 6,903 تعداد دریافت فایل اصل مقاله: 2,249 |